SCHEMBL25626835

SCHEMBL25626835

CC(C)(C)c1cc2ccn(CC(C)(C)c3cc4c(F)c(CC(C)(C)c5cc6cc[nH]c6nc5OCCN5CC(O)C5)[nH]c4nc3OCCN3CCC3)c2nc1OCCN1CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25627483 0.78 CYP1A2 (0.33) —
SCHEMBL25613071 0.76 LTA4H (0.33) —
SCHEMBL25613054 0.73 LTA4H (0.45) —
SCHEMBL25626880 0.66 GRM4 (0.32) —
SCHEMBL25613068 0.65 CYP3A4 (0.45) —
SCHEMBL25627063 0.65 — —
SCHEMBL25624526 0.64 CYP2C19 (0.40) —
SCHEMBL24005765 0.61 LTA4H (0.48) —
SCHEMBL25613052 0.61 ALDH1A1 (0.44) —
SCHEMBL25613050 0.60 FEN1 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159527-A1 COMPOUNDS AS BCL-2 INHIBITORS FOCHON BIOSCIENCES, LTD. (CN) 2023-05-25 — — US disclosed
Send feedback